BIAF

bioAffinity Technologies, Inc.

Services-Commercial Physical & Biological ResearchNasdaq<br>Emerging growth company

Total Trades

9

Buys

7

Sells

0

Largest Trade

N/A

Insiders

7

Institutional Funds

4

Inst. Value

$15K–$50K

Activist Filings

3

Insider Trades

InsiderTitleTypeValueSharesPriceDate
KNIGHT PETER SDirectorBUYN/A8KDec 5, 2022
Anderson Robert A.DirectorBUYN/A4KDec 3, 2022
DIAMOND STUARTDirectorBUYN/A4KDec 3, 2022
Edwards James MichaelCFOGRANTN/A4KNov 29, 2022
Edwards James MichaelCFOBUYN/A2KNov 29, 2022
Zannes MariaPresident, CEOBUYN/A16KNov 22, 2022
Zannes MariaPresident, CEOGRANTN/A18KNov 22, 2022
GIRGENTI STEVENExecutive ChairmanBUYN/A41KNov 8, 2022
Rubin Gary DDirectorBUYN/A16KOct 21, 2022
🔓Seeing ranges? Sign in for exact trade values — free forever

Institutional Ownership

13F filings as of Dec 31, 2025 · 4 funds holding

FundShares
GEODE CAPITAL MANAGEMENT, LLC27K
CITIGROUP INC8K
IFP Advisors, Inc833
MORGAN STANLEY3

Activist & 5%+ Owners

SC 13D/13G filings — investors holding 5%+ of outstanding shares

BIGGER CAPITAL FUND L P

SC 13G · Oct 1, 2025

2.9%

59K shares

Richard K. Crumly

SC 13G · May 14, 2025

11.2%

3.2M shares

Roby P. Joyce

SC 13G · Oct 10, 2023

6.4%

603K shares

View on Google Finance →